Andries D. van der Meer
Many researchers working with organ-on-chip systems are familiar with the challenge of running multiple independent conditions in parallel, similar to what is normally done in tissue culture wells-plates. This becomes even more complicated if long-term experiments are required. In this paper, led by researchers from the University of Bern and their spin-off AlveoliX, a clear example is presented of how innovative platform technology is now becoming increasingly more successful in addressing this major challenge in the field (3). Not only does their platform allow six alveoli-on-chips to run in parallel in a single system, the lung cell co-cultures were stable for at least 21 days.